Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services E...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SAN DIEGO and SAN FRANCISCO, April 30, 2020 /PRNewswire-AsiaNet/ -- Trio Pharmaceuticals, Inc. ("TRIO"), a cancer therapeutics company developing novel dual action antibody drugs, TRIObody(TM), and novel dual action antibody drug conjugates, TRIObody Drug Conjugate(TM) (TDC(TM)) and Ajinomoto Bio-Pharma Services (...
Authors: LATEST ASIANET NEWS RELEASES